期刊文献+

胃癌转移性淋巴结放射免疫示踪的现状与进展 被引量:2

Radioimmuno-tracing of metastatic lymph node for gastric cancer:status quo and progress
原文传递
导出
摘要 淋巴结转移是影响胃癌患者预后的重要因素,准确的淋巴结转移状态评估可以促进个体化的手术实施及预后。放射免疫技术可用于胃癌及转移淋巴结示踪,但研究中尚存在很多有待解决的问题和局限。然而随着单克隆抗体、基因工程抗体及核素分子功能显像等技术的不断发展,这一技术有望同时实现肿瘤靶向、术前显像和术中实时示踪的功能,以进行更准确的肿瘤分期,采取最佳的治疗方案。本文对放射免疫技术在胃癌及转移性淋巴结示踪中的应用现状及前景做一综述。 Lymph node metastasis is one of the factors associated with the prognosis of gastric cancer patients. While precise evaluation of nodal status can promote the personalized surgery and improve prognosis. Although with many unsolved problems and limitations, radioimmune technique can be used to trace gastric cancer and metastatic lymph nodes. With the constant development of monoclonal antibody , genetic engineering antibody, nuclide molecular functional imaging, the radioimmune technique may allow tumor targeting , preoperative imaging, and intraoperative tracing. Therefore, more accurate tumor staging and optimal therapeutic regimen may be possible. This review mainly focuses on the utility of radioimmuno-tracing technique in metastatic lymph node for gastric cancer.
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2015年第3期298-300,共3页 Chinese Journal of Gastrointestinal Surgery
基金 国家自然科学基金(81372364)
关键词 胃癌 淋巴结 放射免疫示踪 Stomach neoplasms Lymph node Radioimmuno-tracing
作者简介 通信作者:管文贤,Email:Guan-wx@163.com
  • 相关文献

参考文献30

  • 1Sano T, Hollowood A. Early gastric cancer: diagnosis and less invasive treatments[J]. Scand J Surg, 2006,95:249-255.
  • 2Kim JC, Hong HK, Roh SA, et al. Efficient targeting of gastric cancer cells using radiolaheled anti-carcinoemhryonic antigen-specific T84.66 fragments in experimental radioimmunoguidedsurgery[J]. Anticancer Res, 2004,24:663-670.
  • 3Pazo Cid RA, Anton A. Advanced HER2-positive gastric cancer: current and future targeted therapies [J]. Crit Rev Oncol Hematol, 2013,85: 350-362.
  • 4Mussa A, Sandrucci S, Mobiglia A, et al. Role of radioimmunolocalization in the staging of gastric carcinoma [J]. Semin Surg Oncol, 1998,15: 209-211.
  • 5Lucisano E, Bertoglio S. Role of radioimmunoguided surgery using iodine-125-labeled B72.3 monoclonal antibody in gastric cancer surgery[J]. Semin Surg Oncol, 1998,15 :212-214.
  • 6Murakami M, Kuroki M, Arakawa F, et al. Binding reactivity of monoclonal anti -carcinoembryonic antigen ( CEA) antibodies with cell membrane-bound CEA and with free CEA in solution [J]. Immunol Invest, 1996,25:23-35.
  • 7Wong JYC, Chu DZ, Yamauchi DM, et al. A phase I radioimmunotherapy trial evaluating 90 yttrium-labeled anticarcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies [J]. Clin Cancer Res, 2000,6:3855-3863.
  • 8Cidon EU, Ellis SG, Inam Y, et al. Molecular targeted agents for gastric cancer: a step forward towards personalized therapy [J]. Cancers, 2013 ,5: 64-91.
  • 9Borjesson PK, Postema EJ , de Bree R, et al. Radioimmunodetection and radioimmunotherapy of head and neck cancer [J]. Oral Oncol, 2004,40:761-772.
  • 10Rahbarizadeh F, Ahmadvand D, Sharif zadeh Z. Nanobody: an old concept and new vehicle for immunotargeting [J]. Immunol Invest, 2011,40:299-338.

二级参考文献147

共引文献30

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部